Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 75/100

BD to Present at Bank of America Securities 2023 Health Care Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of...

Key Takeaway: Becton, Dickinson and Company (BD) announced its participation in the Bank of America Securities 2023 Health Care Conference scheduled for May 9, 2023. The presentation will be accessible through a live webcast on BD's investor relations website, with a replay available afterwards. BD, a significant player in the medical technology sector, highlights its efforts to improve healthcare through innovation and collaboration with healthcare providers and researchers.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is a leading global medical technology company.
  • The presentation at the conference signifies BD's commitment to advancing healthcare.
  • BD offers innovative technologies that enhance clinical processes.

Full Press Release Details

FRANKLIN LAKES, N.J. , April 26, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 11:00 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Francesca DeMartino
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.5743
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the Bank of America Conference?

BD will present on May 9, 2023, at 11:00 am Eastern Time.

How can I access BD's live presentation webcast?

The live webcast can be accessed on BD's investor relations website.

Is there a replay available after BD's presentation?

Yes, a replay will be available on the same webpage after the event.

What is BD's focus as a medical technology company?

BD aims to enhance health through improved medical discovery and care delivery.

How many employees does BD have worldwide?

BD employs approximately 77,000 individuals globally.

Last updated: Apr 26, 2023